The Valley Desk

NCT03719690 · Interventional trial

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

Overall registry status Completed

Phase 2

Conditions HNSCC, HRAS Gene Mutation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov